28239-05-6

Upstream product

• 108-22-5 Isopropenyl acetate 
• 38651-65-9 (1R,5S)-(+)-nopinone 

Downstream Products

• 38651-65-9 (1R,5S)-(+)-nopinone 
• 35408-03-8 (+)-apoverbenone 
• 132345-34-7 Nopinone-2,2-diacetate 
• 82078-77-1 (+)-6,6-dimethyl-2,2-diacetoxy-3-norpinene 
• 145104-69-4 (4R)-4-(4-pentyl-2,6-dihydroxyphenyl)-6,6-dimethyl-2-norpinanone 
• 182509-23-5 (1R,4R,5R)-4-(2,6-dihydroxy-4-(2-methyloctan-2-yl)phenyl)-6,6-dimethylbicyclo[3.1.1]heptan-2-one 
• 132345-25-6 (-)-4-<2,6-Dimethoxy-4-(1,1-dimethylheptyl)phenyl>-6,6-dimethylbicyclo<3.1.1>heptan-2-one 
• 132345-24-5 (-)-4-<2,6-Dimethoxy-4-(1,1-dimethylheptyl)phenyl>-6,6-dimethylbicyclo<3.1.1>hept-3-en-2-one 
• 132345-26-7 4-<2-Hydroxy-4-(1,1-dimethylheptyl)-6-methoxyphenyl>-6,6-methylbicyclo<3.3.1>heptan-2-one 
• 132345-30-3 (-)-4-<2-Hydroxy-4-(1,1-dimethylheptyl)-6-methoxyphenyl>-6,6a-dimethylbicyclo<3.3.1>hept-3-en-2-one 

Relevant academic research and scientific papers

New chiral organosulfur donors related to bis(ethylenedithio) tetrathiafulvalene

Six new enantiopure chiral organosulfur donors, with structures related to BEDT-TTF, have been synthesised for use in the preparation of organic metals, starting either by double nucleophilic substitutions on the bis-mesylate of 2R,4R-pentane-2,4-diol or by a cycloaddition with subsequent elimination of acetic acid on the enol acetate of (+)-nopinone. Crystal structures of some of their radical cation triiodides salts and TCNQ complexes are reported.

Novel Labelled Cannabinergic Ligands and Related Analogs

Novel cannabinoid ligands represented by the general formulas I, II, and III and methods for preparation and use within which one or more of a fluorescent ligand, nitroxide spin label, metal chelate, biotin moiety, or group with enhanced polarity may be incorporated. The compounds can bind to and modulate the cannabinoid CB1 and CB2 receptors and thereby considered specific ligands for these receptors. Some of the disclosed compounds that bind to cannabinoid CB1 and CB2 receptors can exhibit tight or irreversible binding characteristics for these receptors. Due to the presence of the imaging/diagnostic and/or therapeutic functional groups including fluorescent groups, nitroxide spin labels, metal chelates, biotin moieties, and groups with enhanced polarity, the disclosed compounds may be useful as imaging/diagnostic tools and/or therapeutic agents.